Dr. André Stürzenbecher

VP Global Medical Affairs, Therapeutic Area Thrombosis

Bayer

VP Corporate Medical Affairs, Cardiovascular

VP Corporate Medical Affairs, Thrombosis

Main remits of my team are to generate and evaluate medical information and data on the value and safety of Xarelto worldwide, and to pass this information on to external healthcare contacts and experts around the globe, as well as to internal partners such as the sales and marketing teams. 
Task has become increasingly complex over the past few years. The number of players in the healthcare sector that decide on the availability of a product before and after approval is growing, and the demands on the extent and detail of clinical data are by no means restricted to product approval.
 In order to meet the new requirements, my team is intensifying its interaction with key thought leaders, e.g. by further strengthening the Medical Science Liaison organization. 
Another important topic for the team will be meeting the need for data on the practical efficacy of products already available on the market – the keyword here being "real life evidence”. We have several ongoing studies on Xarelto with large numbers of patients are examining its safety and efficacy in long-term use and under everyday conditions – with the aim of supplying further evidence of the product's benefits

VP Corporate Medical Affairs, Medical Strategy Thrombosis

Manage global clinical ACS Life-Cycle-Management and provide Medical Affairs Guidance to PhII-IV clinical activities 
Medical Lead for EMA post approval commitment – PASS protocol development/implementation
Develop and implement a publication strategy and implement KOL Management

Corporate Medical Affairs, Acute Coronary Syndrome

Secure alignment of strategic planning & marketing activities of ADALAT GITS, Pritor/Kinzal
Provide Medical Affairs guidance to global clinical development of Adalat FDC. Manage clinical Life-Cycle-Management and Brand defense Activities (PhIV, NIS). Develop and implement a publication strategy & KOL Management. Support Pharmacovigilance, oversee Regulatory and Legal compliance

Corporate Medical Affairs, Hypertension

Bayer Schering Pharma

Global Strategic Marketing Radiology/PET - Head of Molecular Imaging, Executive Director

Schering Deutschland GmbH

I started as a Product Manager for Diagnostic Imaging in the German subsidiary of the world leading company for Contrast Agents. After taking part in an huge internal strategic project I moved to the newly set-up Business Development department to intensify my business capabilities as a physician.
When Schering started to do its 1st steps in the Oncology arena I took over the Head position for Medical Marketing responsible for the internal staff and in close cooperation with the BU head and the sales force team.

Head Medical Marketing Oncology, Business Analyst, Product Manager

Charité

Resident Diagnostic Imaging and Nuclear Medicine

VP Medical Affairs @ Bayer | Pharma | Cardiovascular | Evidence Generation & Interpretation | CME | Clinical Trials | Medical Strategy |

He who does not desire power is fit to hold it. -Plato
The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant. —Max DePree
#leadership #mindfulness #strategy
#Freunde der Berliner Philharmoniker
#VSaW sailing

Taplio

Dr. André Stürzenbecher's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Dr. André Stürzenbecher's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Dr. André Stürzenbecher's Linkedin Analytics